Drug Shortage Report for CILOXAN
Report ID | 169228 |
Drug Identification Number | 01945270 |
Brand name | CILOXAN |
Common or Proper name | CILOXAN 0.3% SOLUTION |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 0.3% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ML |
ATC code | S03AA |
ATC description | ANTIINFECTIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-09-14 |
Actual start date | 2022-09-14 |
Estimated end date | Unknown |
Actual end date | 2022-10-06 |
Shortage status | Resolved |
Updated date | 2022-10-07 |
Company comments | Release of Lot# 117A9 on Oct 6th |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-10-07 | French | Compare |
v4 | 2022-10-07 | English | Compare |
v3 | 2022-09-15 | English | Compare |
v2 | 2022-09-14 | French | Compare |
v1 | 2022-09-14 | English | Compare |
Showing 1 to 5 of 5